Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 1 (1 total).

Renaud M, Kresse E, Haywood M. 1997. Profiles of activities to reduce perinatal transmission of HIV: Assessing the response. Washington, DC: United States Conference of Mayors, 115 pp.

Annotation: This report assesses the responses of seven health care provider sites to the findings by a pediatric AIDS trial clinic that the drug zidovudine (ZDV), also known as AZT, can reduce perinatal transmission of HIV by as much as two thirds when administered to women during pregnancy and delivery to infants for six weeks after birth. It identifies the range of strategies and activities undertaken and also sheds lights on contextual factors that affected the responses and addresses their implications.

Contact: HathiTrust Digital Library, University of Michigan, Telephone: (734) 764-8016 E-mail: [email protected] Web Site: https://www.hathitrust.org/digital_library Available from Hathitrust via participating libraries. Document Number: HRSA Info. Ctr. MCHJ097.

Keywords: Assessment, Demographics, Evaluation, High risk pregnancy, Infant health promotion, Maternal health, Pediatric AIDS, Pediatric HIV, Perinatal care, Perinatal health, Public health, Risk prevention, Socioeconomic factors, Zidovudine
   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.